Ephraim E. Parent MD, PhD

Dr. Parent is a dual-boarded radiologist and nuclear medicine physician whose research has focused on novel PET radiotracer development. His synthetic interests include androgen receptor PET ligands, estrogen receptor radiotherapeutics for breast cancer, and amino acid suicide inhibitors for the treatment of brain gliomas. His clinical research projects include imaging neuroendocrine prostate cancer transformation with 68Ga-DOTATATE PET/CT and 18F-Axumin PET evaluation of gliomas.